Controlled Substances Classification Table
Hospital Monitoring & Compliance Guide
Inventory Accuracy = (Physical Count / Expected Balance) × 100% ≥ 99.8%
| Category | Drug Examples | Schedule | Storage Requirements | Inventory Checklist | Documentation Requirements | Disposal Protocol |
|---|---|---|---|---|---|---|
| Opioid Analgesics | Morphine, Fentanyl, Oxycodone, Hydromorphone, Codeine | II | Double-locked cabinet; separate safe; temperature controlled; biometric access preferred | Daily physical count; reconcile with administration records; verify expiration dates; witness signature | Patient name, dose, time, prescribing physician, witness signature, lot number, patient ID verification | Reverse distributor; dual witness; DEA Form 222 for returns; documented chain of custody |
| Stimulants | Amphetamine (Adderall), Methylphenidate (Ritalin), Dextroamphetamine, Lisdexamfetamine | II | Locked vault; limited access; alarm system; separate dispensing area; inventory log | Per-shift count; weekly physical inventory; reconcile with dispensing logs; track lot numbers | Prescriber DEA number, patient ID, quantity dispensed, pharmacist verification, indication for use | DEA-authorized destruction; dual witness documentation; certificate of destruction required |
| Sedative-Hypnotics | Pentobarbital, Secobarbital, Phenobarbital (high doses), Amobarbital | II | Secure vault; access log; biometric locks; cool, dry storage; limited personnel access | Daily physical count; reconcile with MAR; verify seals; check temperature logs | Administration time, patient response, waste documentation (partial doses), two-nurse verification | Witnessed destruction; DEA Form 222; maintain destruction logs for 2+ years; video recording |
| Benzodiazepines | Diazepam, Lorazepam, Midazolam, Alprazolam, Clonazepam, Temazepam | IV | Locked cabinet; separate from Schedule II; temperature monitoring; restricted access | Weekly inventory; monthly audit; random counts; reconcile with prescription records | Prescription tracking, patient monitoring chart, sedation scoring, prescriber credentials | Standard pharmaceutical waste; documentation of quantity destroyed; dual witness |
| Ketamine | Ketamine HCl (all forms), Esketamine (Spravato) | III | Locked storage; restricted access; cool storage (2-8°C); separate anesthesia tracking | Bi-weekly inventory; usage tracking by department; reconciliation with surgical records | Anesthesia record, dose calculation, patient weight documentation, procedure type, recovery monitoring | Hazardous waste protocols; witnessed disposal; DEA notification for large quantities |
| Anabolic Steroids | Testosterone cypionate, Nandrolone, Oxandrolone, Stanozolol, Boldenone | III | Locked pharmacy storage; temperature monitored (15-30°C); separate from other controls | Monthly physical count; lot number tracking; expiration monitoring; usage trend analysis | Patient diagnosis justification, injection logs, prescribing physician credentials, informed consent | Return to manufacturer when possible; DEA Form 222 for returns; documentation of return reason |
| Buprenorphine | Suboxone (bup/naloxone), Subutex, Sublocade, Bunavail | III | Secure storage; separate dispensing area; DEA waiver verification required; patient registry | Daily dispensing logs; weekly inventory reconciliation; patient-specific tracking; film/tablet count | Patient counseling documentation, DEA X-waiver verification, induction protocols, treatment plan | Patient return program preferred; DEA-authorized disposal; documented witnessed destruction |
| Cough Preparations | Codeine cough syrup (≥90mg/dose), Hydrocodone cough syrup, Hydrocodone/acetaminophen | II / III | Locked cabinet; age verification protocols; quantity limits enforced; separate inventory | Per-shift counts; dispensing log reconciliation; verify prescription validity; track patient history | Patient ID verification, quantity limits, prescription validity check, pharmacist consultation note | Standard controlled substance disposal; documentation of destruction method; DEA Form 222 if applicable |
| Cannabis-Derived | Dronabinol (Marinol), Cannabidiol (Epidiolex), Cesamet (nabilone) | III / V | Secure, separate storage; state-specific requirements; seed-to-sale tracking where applicable | Daily inventory; state registry reconciliation; lot tracking; patient-specific dispensing records | State registry verification, patient certification, dosing protocols, adverse event monitoring, prescriber registration | State-specific destruction protocols; dual witness required; chain of custody documentation; DEA notification |
| Emergency Opioid Antagonists | Naloxone HCl (high-concentration 4mg/0.1mL, 2mg/2mL auto-injectors) | II / III | Emergency crash carts; temperature controlled (15-30°C); sealed containers; readily accessible | Daily cart checks; seal verification; expiration monitoring; replacement protocol after use; lot tracking | Administration timestamp, response documentation (ROSC), replacement protocols, incident reporting, waste reconciliation | Standard disposal for expired units; incident reporting if used; documentation of medical necessity; restocking verification |
Compliance Index = (Accurate Records × Secure Storage × Proper Disposal) / (Total Inventory Items) × 100
Risk Assessment Score = (Schedule Level × Quantity × Accessibility) / (Security Measures + Monitoring Frequency)
Important Note: This table provides a standardized framework for hospital pharmacy compliance. Specific protocols may vary based on local regulations (state boards of pharmacy), institutional policies, DEA registration requirements, and Joint Commission standards. Always consult current DEA regulations (21 CFR 1301-1308) and your legal compliance officer for jurisdiction-specific requirements.
